Location History:
- Irvine, CA (US) (2013 - 2017)
- Orange, CA (US) (2022)
Company Filing History:
Years Active: 2013-2022
Title: Dan M Cooper: Innovator in Breath Biomarker Detection
Introduction
Dan M Cooper is a prominent inventor based in Irvine, CA. He has made significant contributions to the field of medical technology, particularly in the detection of biomarkers from exhaled breath. With a total of 3 patents, his work focuses on improving asthma and COPD treatment through innovative devices and methods.
Latest Patents
One of Cooper's latest patents is titled "Detection of biomarkers from exhaled breath." This technology involves devices and methods for detecting various biomarkers from a user's exhaled breath. The invention includes a device that comprises a metered dose inhaler and a sensor capable of detecting biomarkers such as HFA, CO, and NO. In another embodiment, the device can detect HFA, CO, and NO simultaneously using photoacoustic spectroscopy. Additionally, this device may be integrated into a comprehensive treatment regimen for asthma or COPD.
Another notable patent is "Approach to asthma inhaler compliance using breath measurement of tetrafluoroethane." This invention focuses on measuring the effectiveness and compliance of inhaler medication for asthma treatment. It provides a method for determining the effectiveness of inhaler medication by measuring HFA-134(a) from an individual's exhaled breath after inhalation. The presence of a high level of HFA-134(a) indicates effective administration of the medication.
Career Highlights
Dan M Cooper is affiliated with the University of California, where he continues to advance research in respiratory health. His innovative work has garnered attention in the medical community, contributing to better management of respiratory conditions.
Collaborations
Cooper has collaborated with notable colleagues, including Hye-Won Shin and Donald R Blake, to further enhance the impact of his inventions in the field of respiratory health.
Conclusion
Dan M Cooper's contributions to the detection of biomarkers from exhaled breath represent a significant advancement in medical technology. His innovative patents are paving the way for improved treatment options for individuals with asthma and COPD.